Implementation of California COVIDNet – a multi-sector collaboration for statewide SARS-CoV-2 genomic surveillance

Autor: Debra A. Wadford, Nikki Baumrind, Elizabeth F. Baylis, John M. Bell, Ellen L. Bouchard, Megan Crumpler, Eric M. Foote, Sabrina Gilliam, Carol A. Glaser, Jill K. Hacker, Katya Ledin, Sharon L. Messenger, Christina Morales, Emily A. Smith, Joel R. Sevinsky, Russell B. Corbett-Detig, Joseph DeRisi, Kathleen Jacobson, the COVIDNet Consortium, Summer Adams, Phacharee Arunleung, Matthew Bacinskas, Cynthia Bernas, Ricardo Berumen, Brandon Brown, Teal Bullick, Lyndsey Chaille, Alice Chen, Giorgio Cosentino, Yocelyn Cruz, Nick D’Angelo, Mojgan Deldari, Alex Espinosa, Ambar Espinoza, Shiffen Getabecha, Madeleine Glenn, Bianca Gonzaga, Ydelita Gonzales, Melanie Greengard, Hugo Guevara, Kim Hansard, April Hatada, Monica Haw, Thalia Huynh, Chantha Kath, Paul B. Kimsey, Deidra Lemoine, Ruth Lopez, Blanca Molinar, Samantha Munoz, Robert Nakamura, Nichole Osugi, Tasha Padilla, Chao-Yang Pan, Mayuri V. Panditrao, Chris Preas, Will Probert, Alexa Quintana, Maria Uribe-Fuentes, Mayra Ramirez, Clarence Reyes, Estela Saguar, Maria Salas, Ioana Seritan, Brandon Stavig, Hilary Tamnanchit, Serena Ting, Cindy Wong, Chelsea Wright, Shigeo Yagi, Venice Servellita, Alicia Sotomayor-Gonzalez, Charles Y. Chiu, Isabel Bjork, Joshua Kapp, Anouk van den Bout, Ellen Kephart, Mawadda Alnaeeli, Hau-Ling Poon, Scott Topper, Marzieh Shafii, Sara Sowko, Stephanie Trammell, Erik Wolfsohn, Patrick Ayscue, Amy Kistler, Emily Crawford, Cristina Tato, Valeria Arboledaz, Eleazar Eskin, Laila M. Sathe, Jacek Skarbinski, Abigail Duque, Jeffrey Schapiro, Ivy Yeung, Rama Ghatti, Zahra Shajani-Yi, Jacob M. Garrigues, Nicole Green, Peera Hemarajata, Carlos Anaya, Donna Ferguson, Beatrix Kapuszinsky, Favian Ramirez, Felipe Sta Agueda, Julia Wolfe, David Haussler, Marc Perry, Jakob McBroome, Nhi Duong, Deborah Forester, Anthony Gonzalez, Maria J. Victorio, Anna Liza M. Manlutac, Jeremy Corrigan, Nicholas S. Rhoades, Lina Castro, Godfred Masinde, Harmeet Kaur, Monica Paniagua-Alexander, Katrina G. Erwin, Glen Miller, Frances N. Sidhu, Morris Jones, Sangita Kothari, Christopher Ngo, Brandon Bonin, Daniel Castillo, Rensen Khoshabian, Kristian Andersen, Mark Zeller, Lisa Critchett, Carlos Gonzalez, Iryna V. Goraichuk, Rachel Rees, Frank Ambrosio, Curtis J. Kapsak, Kevin G. Libuit, Michelle R. Scribner, Sage M. Wright, Vanessa B. Cadiz, Denise Lopez, Matthew Rosman, Bryan Bach, Stacia Wyman, Charlotte Acharya, Ryan Davis, Richard Michelmore, Melanie Oakes, Suzanne Sandmeyer, Kathy Borkovich, Clay H. Clark, Holly Clark, Brandon Le, Peter De Hoff, Kristen Jepsen, Rob Knight, Louise C. Laurent, Zack Aralis, Carolina Arias, Varuzhan Balasanyan, Mark Duhon, Xinmin Li, Eric Chow, Nicole Leung, Delsy Martinez, Tyler T. Miyasaki, Ashlee Clow, Jared Hoffman, Thomas Rush

Publikováno v: Frontiers in Public Health, Vol 11 (2023)

IntroductionThe SARS-CoV-2 pandemic represented a formidable scientific and technological challenge to public health due to its rapid spread and evolution. To meet these challenges and to characterize the virus over time, the State of California esta

Externí odkaz: https://doaj.org/article/70d4419c72944f60bdbb705c74bc8a0f

Supplementary Methods, Supplementary Tables 1 through 7, and Supplementary Figures 1 through 7 from Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

Autor: Ingo K. Mellinghoff, Lisa M. DeAngelis, Nikolaus Schultz, Thomas G. Graeber, Katherine S. Panageas, Jason T. Huse, Philip H. Gutin, Anne S. Reiner, Vaios Hatzoglou, Enrico C. Lallana, Scott Peak, Jon Glass, Minhee Won, Ahmet Dogan, Julia Wolfe, Craig H. Moskowitz, Craig S. Sauter, Paul Hamlin, M. Lia Palomba, Ariela Noy, Elina Tsyvkin, Alissa A. Thomas, Elena Pentsova, Antonio Omuro, Craig P. Nolan, Thomas J. Kaley, Igor T. Gavrilovic, Cameron W. Brennan, Viviane S. Tabar, Agnes Viale, Marc Rosenblum, Dan Rohle, Wan-Ying Hsieh, Owen Clark, Donna Nichol, Paolo Codega, Derrek Schartz, Carl Campos, Sarah S. Tang, Nicolaos Palaskas, Alessandro Pastore, Christian Grommes

Supplementary Methods. Supplementary Table S1: Baseline characteristics of PCNSL Patients. Supplementary Table S2: Baseline characteristics of SCNSL patients. Supplementary Table S3: Corticosteroid use. Supplementary Table S4: Genes with Recurrent Mu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846702464e3ab3c289e6186006db05bc
https://doi.org/10.1158/2159-8290.22532099

Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile

Autor: Ryna Mathias, Allyson J. Ocean, Hooman Kamel, Lisa M. DeAngelis, Glen C. Jickling, Bradley P. Ander, Babak B. Navi, Frank R. Sharp, Scott T. Tagawa, Ashish Saxena, Julia Wolfe, Boryana Stamova, Heather Hull, Carla P Sherman, Costantino Iadecola, Mitchell S.V. Elkind

Publikováno v: Stroke

Background and Purpose— Comorbid cancer is common in patients with acute ischemic stroke (AIS). As blood mRNA profiles can distinguish AIS mechanisms, we hypothesized that cancer-related AIS would have a distinctive gene expression profile. Methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36387f8b1a13fd083b30c69c6ed53c6
https://doi.org/10.1161/strokeaha.119.026143

Staging Identifies Non-CNS malignancies in a Large Cohort with Newly Diagnosed Lymphomatous Brain Lesions

Autor: Christian Grommes, Julia Wolfe, Rachna Malani, Ankush Bhatia

Publikováno v: Leuk Lymphoma

Lymphomatous brain lesions can represent primary central nervous system (CNS) lymphoma or secondary involvement as part of systemic disease (SCNSL). In this study, we characterize staging evaluations in a large patient cohort with newly-diagnosed bra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3744b329f64b36cc47e73433425e8b24
https://europepmc.org/articles/PMC6620158/

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

Autor: Malbora Manne, Anne S. Reiner, Andrew L. Lin, Lisa M. DeAngelis, Christian Grommes, Jacqueline B. Stone, Mariza Daras, Vaios Hatzoglou, Alissa A. Thomas, Sarah S. Tang, Elena Pentsova, Ingo K. Mellinghoff, Katherine S. Panageas, Craig Nolan, Carl Campos, Agnes Viale, Anna F. Piotrowski, Paolo Codega, Julia Wolfe, Thomas Kaley, Michael F. Berger

Publikováno v: Blood. 133(5)

Ibrutinib is a first-in-class inhibitor of Bruton tyrosine kinase (BTK) and has shown single-agent activity in recurrent/refractory central nervous system (CNS) lymphoma. Clinical responses are often transient or incomplete, suggesting a need for a c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4803904aaf89d499c01a9a8486f02a5c
https://pubmed.ncbi.nlm.nih.gov/30567753